.... Methods: When a small (≤1 cm) papillary recurrence of a NMIBC was diagnosed, the patient could choose between immediate transurethral resection of the bladder (TURB) or four weekly intravesical instillations with mitomycin C (MMC) or epirubicin (ERC). Control cystoscopy was scheduled 2-3 weeks after...

... and epirubicin alone and in combination were determined. Material and Methods: Human urothelial cancer cell lines HT1197 and HT1376 were exposed in vitro for 1 h to different concentrations of epirubicin (0.02–2 mg/ml) and for 72 h to ciprofloxacin (0.004–0.8 mg/ml). Cytotoxicity was determined using...

...Levent Türkeri; Yılören Tanıdır; Çağ Çal; Haluk Özen; Hayrettin Şahin; and members of the Turkish Urooncology Society Objectives: To investigate the efficacy of single or double epirubicin instillation during the early postoperative period (EPP) in intermediate-risk non-muscle-invasive urothelial...

...Ali Erol; Suat Özgür; Murat Basąr; Selahattin Çetin The efficacy and side effects of the prophylactic intravesical bacillus Calmette-Guérin and epirubicin combination therapy were evaluated in 14 patients who underwent transurethral resection for Ta–T1 superficial bladder cancer. Therapy...

... dissemination, commencement of instillation therapy at an early postoperative period is preferred. However, increased drug permeability is suspected because of damage to the bladder mucosa during operation. Therefore, this study was conducted to investigate the plasma level of epirubicin (EPI) instilled...